Dermapharm Holding SE
DMPHF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $2,224 | $2,079 | $2,146 | $2,021 |
| - Cash | $121 | $159 | $150 | $160 |
| + Debt | $980 | $1,080 | $516 | $580 |
| Enterprise Value | $3,083 | $3,001 | $2,513 | $2,441 |
| Revenue | $1,181 | $1,151 | $1,025 | $943 |
| % Growth | 2.6% | 12.3% | 8.7% | – |
| Gross Profit | $767 | $704 | $661 | $621 |
| % Margin | 65% | 61.2% | 64.5% | 65.8% |
| EBITDA | $321 | $263 | $324 | $357 |
| % Margin | 27.2% | 22.8% | 31.6% | 37.9% |
| Net Income | $114 | $62 | $134 | $210 |
| % Margin | 9.6% | 5.4% | 13.1% | 22.2% |
| EPS Diluted | 2.11 | 1.16 | 2.49 | 3.89 |
| % Growth | 81.9% | -53.4% | -36% | – |
| Operating Cash Flow | $201 | $219 | $289 | $250 |
| Capital Expenditures | -$38 | -$42 | -$39 | -$61 |
| Free Cash Flow | $163 | $178 | $250 | $189 |